Skip to main content
Signal8
Brun Scott C. profile photo

Scott C. Brun

CIK: 0001863614

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)8 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Forte Biosciences, Inc. logo
FBRX

Forte Biosciences, Inc.

Director
Cabaletta Bio, Inc. logo
CABA

Cabaletta Bio, Inc.

Director
Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition(D)

    Stock Option (right to buy)

    Direct
    2K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition(D)

    Restricted Stock Units

    Direct
    18.4K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition(D)

    Stock Option (right to buy)

    Direct
    31K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition(D)

    Stock Option (right to buy)

    Direct
    2K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition(D)

    Stock Option (right to buy)

    Direct
    1K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    Jun 9, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    May 29, 2026
    Award(A)

    Restricted Stock Units

    Direct
    18.4K shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 3, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    7.5K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    Jun 9, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Disposition(D)

    Stock Option (Right to Buy)

    Direct
    44K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    44K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Disposition(D)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Disposition(D)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Cabaletta Bio, Inc. logo
    CABA

    Cabaletta Bio, Inc.

    May 19, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    22K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Mar 20, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    31K shares-

1-16 of 16

About Brun Scott C.

Brun Scott C. (SEC CIK 0001863614) files insider reports with the SEC as Director of Forte Biosciences, Inc. (FBRX), Director of Cabaletta Bio, Inc. (CABA) and Director of Jasper Therapeutics, Inc. (JSPR).

Signal8 holds 7 ownership filings by Brun Scott C., all Form 4s, filed between Mar 21, 2025 and Aug 27, 2026. Those filings report 16 transactions, from Mar 20, 2025 to Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brun Scott C.'s filings is in DALLAS, TX.

Recent filings by Brun Scott C.

  • Aug 27, 2026: Disposition to issuer transactions of FBRX derivative securities (5 lines, Form 4, code D).
  • Jun 9, 2026: Grant or award of CABA derivative securities (Form 4, code A).
  • May 29, 2026: Grant or award of FBRX derivative securities (Form 4, code A).
  • Jul 3, 2025: Grant or award of JSPR derivative securities (Form 4, code A).
  • Jun 9, 2025: Grant or award of CABA derivative securities (Form 4, code A).

Other insiders filing for Forte Biosciences, Inc. (FBRX)

How to read Form 4 transaction codes